Scientist, Teva PharmaceuticalsBiography
Dr. Khandelwal is currently led the critical reagent generation group at the Teva Pharmaceuticals. Puneet group focused on cloning, expression, purification and characterization of recombinant proteins, and evaluate and establish several platform mammalian expression systems. Puneet has vast experience in molecular and cell biology, and is recipient of several fellowships and grants. He received his doctorate from Jawaharlal Nehru University, India and completed postdoctoral fellowship at the University of Pittsburgh School of Medicine.